Attenuation of Proinflammatory Response by Recombinant Human IL-10 in Human Endotoxemia: Effect of Timing of Recombinant Human IL-10 Administration

Journal of Immunology

Volumn 158, Issue 8, 1997, Pages 3971-3977

  Pajkrt, Dasja ^a,c   Camoglio, Luisa ^a   Tiel Van Buul, Monique C M ^a   De Bruin, Kora ^a   Cutler, David L ^b   Affrime, Melton B ^b   Rikken, Ger ^b   Van Der Poll, Tom ^a   Ten Cate, Jan Wouter ^a   Van Deventer, Sander J H ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b MERCK RESEARCH LABORATORIES   (United States)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; RECOMBINANT PROTEIN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ENDOTOXEMIA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; TIME; TREATMENT OUTCOME;

ADULT; DOUBLE-BLIND METHOD; ENDOTOXEMIA; HUMANS; INJECTIONS, INTRAVENOUS; INTERLEUKIN-10; MALE; RECOMBINANT PROTEINS; TIME FACTORS; TREATMENT OUTCOME;

EID: 0031569474     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. De Waal Malefyt, R., J. Abrahams, B. Bennett, C. G. Figdor, and J. E. de Vries. 1991. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174:1209.
2. Moore, K. W., A. O'Garra, R. de Waal Malefyt, P. Vieira, and T. R. Mosmann. 1993. Interleukin-10. Annu. Rev. Immunol. 11:165.
3. Howard, M., and A. O'Garra. 1992. Biological properties of IL-10. Immunol. Today 13:198.
4. Fiorentino, D. F., A. Zlotnik, T. R. Mosmann, M. Howard, and A. O'Garra. 1991. IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 147: 3815.
5. Bogdan, C., Y. Vodovotz, and C. Nathan. 1991. Macrophage deactivation by interleukin-10. J. Exp. Med. 174:1549.
6. Cassatella, M. A., L. Meda, S. Bonora, M. Ceska and G. Constantin. 1993. Interleukin 10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes: evidence for an autocrine role of tumor necrosis factor and IL-1β in mediating the production of IL-8 triggered by lipopolysaccharide. J. Exp. Med. 178:2207.
7. Wang, P., P. Wu, J. C. Anthes, M. I. Siegel, R. W. Egan, and M. M. Billah. 1994. Interleukin-10 inhibits interleukin-8 production in human neutrophils. Blood 83: 2678.
8. Kasama, T., R. M. Strieter, N. W. Lukacs, M. D. Burdick, and S. L. Kunkel. 1994. Regulation of neutrophil-derived chemokine expression by IL-10. J. Immunol. 152:3559.
9. Cassatella, M. A., L. Meda, S. Gasperini, F. Calzetti, and S. Bonora. 1994. Interleukin-10 (IL-10) up-regulates IL-1 receptor antagonist production from lipopolysaccharide-stimulated human polymorphonuclear leukocytes by delaying mRNA degradation. J. Exp. Med. 179:1695.
10. Gérard, C. C. Bruyns, A. Marchant, D. Abramowicz, P. Vandenabeele, A. Delvaux, W. Fiers, M. Goldman, and T. Velu. 1993. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J. Exp. Med. 177:547.
11. Howard, M., T. Muchamuel, S. Andrade, and S. Nmenon. 1993. Interleukin 10 protects mice from lethal endotoxemia. J. Exp. Med. 177:1205.
12. Mulligan, M. S., M. L. Jones, A. A. Vaporciyan, M. C. Howard, and P. A. Ward. 1993. Protective effects of IL-4 and IL-10 against immune complex-induced lung injury J. Immunol. 151:5666.
13. Shanley, T. P., H. Schmal, H. P. Friedl, M. L. Jones, and P. A. Ward. 1995. Regulatory effects of intrinsic IL-10 in IgG immune complex-induced lung injury J. Immunol. 154:3454.
14. Chernoff, A. E., E. V. Granowitz, L. Shapiro, E. Vannier, G. Lonnemann, J. B. Angel, J. S. Kennedy, A. R. Rabson, S. M. Wolff, and C. A. Dinarello. 1995. A randomized, controlled trial of IL-10 in humans: inhibition of inflammatory cytokine production and immune responses. J. Immunol. 154:5492.
15. Huhn, R. D., E. Radwanski, S. M. O'Connell, M. G. Sturgill, L. Clarke, R. P. Cody, M. B. Affrime, and D. L. Cutler. 1996. Pharmacokinetics and immunomodulatory properties of intravenously administered recombinant human interleukin-10 in healthy volunteers. Blood 87:699.
16. Sturk, A., K. Joop, J. W. ten Cate, and L. L. M. Thomas. 1985. Optimalization of a chromogenic assay for endotoxin in blood. In Bacterial Endotoxins: Structure Biomedical Significance, and Detection with the Limulus Amebocyte Lysate Test. J. W. ten Cate, H. R. Büller, A. Sturk, and J. Levin, eds. Alan R. Liss, New York, p. 117.
17. 1-antitrypsin and lactoferrin in sepsis: evidence for neutrophils as mediators of fatal sepsis. J. Lab. Clin. Med. 119:159.
18. Peters, A. M., and J. P. Lavender. 1991. Imaging inflammation with radiolabelled white cells: 99Tcm-HMPAO or 111IN? Nucl. Med. Commun. 12:923.
19. Van Deventer, S. J. H., H. R. Büller, J. W. ten Cate, L. A. Aarden, C. E. Hack, and A. Sturk. 1990. Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways. Blood 76:2520.
20. 23). J. Infect. Dis. 172:144.
21. Van der Poll, T., S. J. H. van Deventer, M. Levi, H. ten Cate, and J. W. ten Cate. 1994. Tumor necrosis factor is involved in the appearance of interleukin-1 receptor antagonist in endotoxemia. J. Infect. Dis. 169:665.
22. 2 integrins in vivo. Proc. Natl. Acad. Sci. USA 88:7538.
23. Erzurum, S. C., G. P. Downey, B. Schwab III, E. L. Elson, and G. S. Worthen. 1992. Mechanisms of lipopolysaccharide-induced neutrophil retention: relative contributions of adhesive and cellular mechanical properties. J. Immunol. 149: 154.
24. Arfors, K. E., C. Lundberg, L. Lindbom, K. Lundberg, P. G. Beatty, and J. M. Harlan. 1987. A monoclonal antibody to the membrane glycoprotein complex CD18 inhibits polymorphonuclear leukocyte accumulation and plasma leakage in vivo. Blood 69:338.
25. Van der Poll, T., S. J. H. van Deventer, C. E. Hack, G. J. Wolbrink, L. A. Aarden, H. R. Büller, and J. W. ten Cate. 1992. Effects on leukocytes after injection of tumor necrosis factor into healthy humans. Blood 79:693.
26. Van der Poll, T., M. Levi, S. J. H. van Deventer, H. ten Cate, B. L. Haagmans, B. B. Biemond, H. R. Büller, C. E. Hack, and J. W. ten Cate. 1994. Differential effects of anti-tumor necrosis factor monoclonal antibodies on systemic inflammatory responses in experimental endotoxemia in chimpanzees. Blood 83:466.
27. Cupps, T. R., and A. S. Fauci. 1982. Corticosteroid-mediated immunoregulation in man. Immunol. Rev. 65:133.
28. Tanigushi, T. 1988. Regulation of cytokine gene expression. Annu. Rev. Immunol. 6:439.
29. Barber, A. E., S. M. Coyle, M. A. Marano, E. Fischer, S. E. Calvano, Y. Fong, L. L. Moldawer, and S. F. Lowry. 1993. Glucocorticoid therapy alters hormonal and cytokine responses to endotoxin in man. J. Immunol. 150:1999.
30. Van der Poll, T., A. E. Barber, S. M. Coyle, and S. F. Lowry. 1997. Hypercortisolemia enhances interleukin 10 release during human endotoxemia. J. Clin. Endocrinol. Metab. In press.
31. Di Santo, E., M. Sironi, P. Pozzi, P. Gnocchi, A. M. Isetta, A. Delvaux, M. Goldman, A. Marchant, and P. Ghezzi. 1995. Interleukin-10 inhibits lipopolysaccharide-induced tumor necrosis factor α and interleukin-1β production in the brain without affecting the activation of the hypothalamus-pituitary-adrenal axis. Neuroimmunomodulation 2:149.
32. Greenberger, M. J., R. M. Strieter, S. L. Kunkel, J. M. Danforth, R. E. Goodman, and T. J. Standiford. 1995. Neutralization of IL-10 increases survival in a murine model of Klebsiella pneumoniae. J. Immunol. 155:722.